Search for a trial

An Open-label, Phase 2 Study of ACP-196 in Subjects
with Waldenström Macroglobulinemia

The purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics and activity of ACP-196 in treating subjects with Waldenström disease.

An Open-label, Phase 2 Study of ACP-196 in Subjects with Mantle Cell Lymphoma

The purpose of this study is to evaluate the efficacy, activity, safety, pharmacodynamics and pharmacokinetics of ACP-196 in treating subjects with Mantle Cell Lymphoma (MCL)